18.52
Apnimed, Inc. Common Stock stock is traded at $18.52, with a volume of 268.25K.
It is up +1.65% in the last 24 hours and down -34.05% over the past month.
See More
Previous Close:
$18.22
Open:
$18.18
24h Volume:
268.25K
Relative Volume:
0.53
Market Cap:
$771.00M
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
-13.90%
1M Performance:
-34.05%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Apnimed, Inc. Common Stock Stock (APMD) Company Profile
Name
Apnimed, Inc. Common Stock
Sector
Industry
Phone
-
Address
-
Compare APMD vs VRTX, MRNA, REGN, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
APMD
Apnimed, Inc. Common Stock
|
18.52 | 771.00M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
510.08 | 129.29B | 12.34B | 4.34B | 3.71B | 16.87 |
|
MRNA
Moderna Inc
|
225.00 | 89.83B | 2.23B | -3.19B | -1.60B | -8.1462 |
|
REGN
Regeneron Pharmaceuticals Inc
|
746.54 | 76.86B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
825.03 | 51.88B | 4.16B | 1.29B | 734.26M | 19.58 |
|
RVMD
Revolution Medicines Inc
|
189.76 | 40.67B | 742.00K | -1.37B | -1.07B | -7.0731 |
Apnimed, Inc. Common Stock Stock (APMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-26 | Initiated | BofA Securities | Buy |
| Aug-25-26 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-25-26 | Initiated | Evercore ISI | Outperform |
Apnimed, Inc. Common Stock Stock (APMD) Latest News
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Apnimed, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Apnimed (APMD) CEO Lind logs large stock option reclassification and vesting terms - Stock Titan
Apnimed, Inc. (APMD) Company Information - Simply Wall Street
Apnimed (APMD) Stock Price, News & Analysis - Stock Titan
Apnimed Announces Pricing of Upsized Initial Public Offering - PR Newswire
Apnimed prices IPO at $16 per share, raising $192 million - Investing.com
Apnimed closes upsized IPO, raising $220.8 million - scanx.trade
Apnimed prices IPO at $16 per share, raising $192 million - Investing.com
Apnimed Seeks IPO For OSA Treatment Commercialization (APMD) - Seeking Alpha
S-1 - SEC.gov
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia
Apnimed, Inc. Common Stock Stock (APMD) Financials Data
There is no financial data for Apnimed, Inc. Common Stock (APMD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Apnimed, Inc. Common Stock Stock (APMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SEKHRI PAUL J | Director |
Aug 03 '26 |
Buy |
16.00 |
12,500 |
200,000 |
12,500 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):